RP-HPLC method development, validation, and greenness profile evaluation: Concurrent quantification of telmisartan and atorvastatin calcium in combined pharmaceutical formulation
Acta Chromatographica · 29.05.2026 · 38 (2) · 352-365
DOI: 10.1556/1326.2025.01374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Chromatographica, erschienen am 29.05.2026. Verfasst von Sarad Pawar Naik Bukke und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Large Research Project.
Abstract (Originalsprache)
Objectives
When formulating new strategies, contemporary analysts prioritize sustainability. Research in green analytical chemistry aims to replace hazardous reagents with eco-friendly alternatives and minimize waste generation. This study employed a comprehensive assessment of greenness evaluation tools. A newly validated RP-HPLC method was subsequently applied for the quantitative analysis of Telmisartan (TEL) and Atorvastatin calcium (ATV Ca) in both pure form and tablet formulation.
Methods
The analysis utilized an HPLC-UV Youngling Acme 9000 system with an Inertsil ODS RP column (250 × 4.6 mm, 5 μm), operating at 250 nm. The mobile phase, a 60:40 (v/v) blend of acetonitrile and phosphate buffer (pH 3.5), was delivered at 1.50 mL min −1 under isocratic conditions. Telmisartan (TEL) and Atorvastatin calcium (ATV Ca) showed retention times of 2.75 and 5.33 min, respectively.
Results
Calibration curves were developed to evaluate the linearity of TEL (10–100 μg mL −1 ) and ATV Ca (2.5–25 μg mL −1 ), showing a high R 2 of 0.999. The LOD and LOQ for TEL were 0.41 μg mL −1 and 0.23 μg mL −1 , while for ATV Ca, they were 1.246 μg mL −1 and 0.695 μg mL −1 , with recoveries averaging 98.59%–99.95% and 99.57%–99.98%, respectively. Validation of the method was performed following ICH guidelines. Moreover, the greenness assessment of the HPLC method was assessed using the AES, NEMI, AGP, AGREE, ComplexMoGAPI, AMGS, and BAGI.
Conclusion
This study validates the newly developed method and evaluates its environmental impact with multiple evaluation tools, confirming its eco-friendly nature, highlighting its potential as a responsible choice for analysing the mixture, especially in quality control labs and the pharmaceutical industry.
Förderung
- Large Research Project
Zitieren
APA
Bukke, S. P. N., Kusuma, P. K., Bhadru, B., Shanmugam, S. T., Kumarachari, R. K., Narapureddy, B. R., & Onohuean, H. (2026). RP-HPLC method development, validation, and greenness profile evaluation: Concurrent quantification of telmisartan and atorvastatin calcium in combined pharmaceutical formulation. Acta Chromatographica, 38(2), 352-365. https://doi.org/10.1556/1326.2025.01374
Vancouver
Bukke SPN, Kusuma PK, Bhadru B, Shanmugam ST, Kumarachari RK, Narapureddy BR, et al. RP-HPLC method development, validation, and greenness profile evaluation: Concurrent quantification of telmisartan and atorvastatin calcium in combined pharmaceutical formulation. Acta Chromatographica. 2026;38(2):352-365. doi:10.1556/1326.2025.01374
BibTeX
@article{Bukke2026,
author = {Bukke, Sarad Pawar Naik and Kusuma, Praveen Kumar and Bhadru, Banothu and Shanmugam, Saraswathi Tenpattinam and Kumarachari, Rajasekhar Komarla and Narapureddy, Bayapa Reddy and Onohuean, Hope},
title = {RP-HPLC method development, validation, and greenness profile evaluation: Concurrent quantification of telmisartan and atorvastatin calcium in combined pharmaceutical formulation},
journal = {Acta Chromatographica},
year = {2026},
volume = {38},
number = {2},
pages = {352--365},
doi = {10.1556/1326.2025.01374}
}
EUVIMED